NCT02933450View on ClinicalTrials.gov

Relypsa For ED Acute Hyperkalemia Control and Reduction (REDUCE)

PHASE4CompletedINTERVENTIONAL
Enrollment

43

Participants

Timeline

Start Date

August 31, 2016

Primary Completion Date

August 31, 2017

Study Completion Date

August 31, 2017

Conditions
Kidney Failure, Chronic
Interventions
DRUG

Patiromer 25.2 g

Single dose of Patiromer 25.2 g

Trial Locations (1)

77030

Ben Taub Hospital, Houston

All Listed Sponsors
collaborator

Relypsa, Inc.

INDUSTRY

lead

Baylor College of Medicine

OTHER

NCT02933450 - Relypsa For ED Acute Hyperkalemia Control and Reduction (REDUCE) | Biotech Hunter | Biotech Hunter